14 Jan

Secondary Trading Notice

ASX ANNOUNCEMENT ECS Botanics Holdings Ltd (ASX:ECS) 14 January 2022 Secondary Trading Notice This notice is given by ECS Botanics Holdings Ltd (ASX: ECS or Company ) under section 708A(5)(e) of the Corporations Act 2001 (Act). Further to the Appendix 2A released today, a total of 1,515,152 fully paid ordinary shares ( Shares ) were issued pursuant to shareholder approval received on 17 December 2021 regarding directors participation in the share placement announced on 29 October 2021. Secondary Trading Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001 (Act) The Act restricts the on-sale of securities issued without disclosure, unless the sale is exempt under section 708 or 708A of the Act. By giving this notice, a sale of the Shares noted above will fall within the exemption in section 708A(5) of the Act. Pursuant to sections 708A(5)(e) and 708A(6) of the Act, the Issuer gives notice that: 1) the Shares were issued without disclosure to investors under Part 6D.2 of the Act; 2) as at the date of this notice, the Issuer has complied with: a) the provisions of Chapter 2M of the Act, as they apply to the Issuer; and b) section 674 of the Act; and 3) as at the date of this notice, other than as set out below, there is no information that is ‘excluded information’ within the meanings of section 708A(7) and 708A(8) of the Act. -ENDS- About ECS Botanics Holdings Ltd ECS Botanics Holdings Ltd is a leading medicinal cannabis and hemp business. The company owns farms and medicinal cannabis facilities in Tasmania and Victoria for the cultivation, processing, and manufacturing of medicinal cannabis. ECS manufactures to EU GMP standards and also has the necessary licences to cultivate and manufacture medicinal cannabis for the wholesale extract, final dose and premium dry flower market. ECS cultivates hemp for the wholesale market and its retail food and wellness brand, while having obtained all the necessary licences to grow, supply and manufacture. ECS’ core focus is scale and low-cost production, without compromising quality. For further information, please contact: Alexander Keach, Managing Director info@ecs-botanics.com Authorised on behalf of ECS by Alex Keach, Managing Director
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2022 Listcorp. ABN 60 166 140 307

Never miss news from ECS Botanics Holdings Ltd (ASX:ECS) when you join Listcorp.